Bernard Fermini
Corporate Officer/Principal en Society of Toxicology .
Perfil
Bernard Fermini is a member of the Society of Toxicology and the Health & Environmental Sciences Institute.
He was previously the Director of the Safety Pharmacology Society and the Head-Ion Channel Discipline at Pfizer Inc. He also served as the Chief Research & Development Officer at Novoheart Holdings, Inc. and the Chief Scientific Officer & VP-Toxicology at Coyne Scientific LLC.
Fermini received his undergraduate degree from the University of Montréal and his doctorate from the University of Sherbrooke.
He is currently employed in his roles at the Society of Toxicology and the Health & Environmental Sciences Institute.
Cargos activos de Bernard Fermini
| Empresas | Cargo | Inicio |
|---|---|---|
Society of Toxicology
 Society of Toxicology Miscellaneous Commercial ServicesCommercial Services The Society of Toxicology is an organization that unites 8,000 professionals in the field of toxicology from all over the world. The non-profit company is based in Reston, VA. The company's goal is to promote scientific advancements and provide support to toxicologists. | Corporate Officer/Principal | - |
| Health & Environmental Sciences Institute | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Bernard Fermini.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVOHEART HOLDINGS INC. | Director Técnico/Científico/I+D | 31/07/2020 |
| Coyne Scientific LLC | Director Técnico/Científico/I+D | 01/08/2018 |
| PFIZER, INC. | Corporate Officer/Principal | 01/10/2016 |
| Safety Pharmacology Society | Director/Miembro de la Junta | - |
Formación de Bernard Fermini.
| University of Montréal | Undergraduate Degree |
| University of Sherbrooke | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Novoheart Holdings, Inc.
 Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada. | Health Technology |
| Coyne Scientific LLC | |
Society of Toxicology
Society of Toxicology Miscellaneous Commercial ServicesCommercial Services The Society of Toxicology is an organization that unites 8,000 professionals in the field of toxicology from all over the world. The non-profit company is based in Reston, VA. The company's goal is to promote scientific advancements and provide support to toxicologists. | Commercial Services |
| Health & Environmental Sciences Institute | |
| Safety Pharmacology Society |
- Bolsa de valores
- Insiders
- Bernard Fermini
